| Title |
Perioperative management of a patient undergoing Clagett window closure stabilized on Suboxone® for chronic pain: a case report
|
|---|---|
| Published in |
Canadian Journal of Anesthesia/Journal canadien d'anesthésie, July 2014
|
| DOI | 10.1007/s12630-014-0193-y |
| Pubmed ID | |
| Authors |
Alexander Huang, Rita Katznelson, Marc de Perrot, Hance Clarke |
| Abstract |
Buprenorphine is a semisynthetic opioid with both agonist and antagonist activity at the opioid receptor. Currently, buprenorphine is commonly available in sublingual preparations combined with naloxone (e.g., Suboxone(®), Subutex(®)). There has been increased use of buprenorphine derivatives in the areas of substance addiction and chronic pain. Nevertheless, there is limited and conflicting information in the literature pertaining to the optimal management of buprenorphine-stabilized patients presenting for surgery. We present our experience with a chronic pain patient on buprenorphine presenting for thoracic surgery. |
Mendeley readers
The data shown below were compiled from readership statistics for 37 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 3% |
| Unknown | 36 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 6 | 16% |
| Researcher | 5 | 14% |
| Student > Doctoral Student | 4 | 11% |
| Student > Postgraduate | 4 | 11% |
| Student > Ph. D. Student | 3 | 8% |
| Other | 8 | 22% |
| Unknown | 7 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 19 | 51% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 8% |
| Nursing and Health Professions | 2 | 5% |
| Arts and Humanities | 1 | 3% |
| Biochemistry, Genetics and Molecular Biology | 1 | 3% |
| Other | 2 | 5% |
| Unknown | 9 | 24% |